PIL - Oxybutynin hydrochloride 2.5mg, 5mg Tablets: Change history
View Patient Information Leaflet (PIL - Oxybutynin hydrochloride 2.5mg, 5mg Tablets)
Last updated on this site: 24 Sep 2025
Addition of an alternative site responsible for importation and batch release, batch control/testing, primary packaging and secondary packaging of the finished product:
Accord Healthcare single member S.A., 64th Km National Road Athens, Lamia, Schimatari, 32009, Greece.
The package leaflet is updated accordingly.
Last updated on this site: 24 Sep 2025
Addition of an alternative site responsible for importation and batch release, batch control/testing, primary packaging and secondary packaging of the finished product:
Accord Healthcare single member S.A., 64th Km National Road Athens, Lamia, Schimatari, 32009, Greece.
The package leaflet is updated accordingly.
-
Changes: (Updated: 24 Sep 2025)
Addition of an alternative site responsible for importation and batch release, batch control/testing, primary packaging and secondary packaging of the finished product:
Accord Healthcare single member S.A., 64th Km National Road Athens, Lamia, Schimatari, 32009, Greece.
The package leaflet is updated accordingly.
-
Changes: (Updated: 21 Aug 2023)
Description of update: To update SmPC and PIL in-line with reference product information (Ditropan Tabletten 5 mg; MA Number: Z.Nr. : 1-18728; MAH: CHEPLAPHARM Arzneimittel GmbH, Deutschland ) for Oxybutynin hydrochloride 2.5/5 mg tablets
PIL sections updated: 3, 4, 6.
-
Changes: (Updated: 21 Sep 2022)
Initial upload